佰金生命科学(01466.HK) 公布3月止财政年度业绩,收入录得1.36亿元,按年增加152.5%。亏损由上年度745万元,收窄至32万元,每股亏损0.05仙。不派息。过往派息公布日期派息事项派息内容2024/11/29中期业绩无派息2024/07/31末期业绩无派息2023/11/28中期业绩无派息2023/06/28末期业绩无派息公司股份已申请周一(28日)恢复买卖。(de/d)(港股报价...
Source Link佰金生命科学(01466.HK) 公布3月止财政年度业绩,收入录得1.36亿元,按年增加152.5%。亏损由上年度745万元,收窄至32万元,每股亏损0.05仙。不派息。过往派息公布日期派息事项派息内容2024/11/29中期业绩无派息2024/07/31末期业绩无派息2023/11/28中期业绩无派息2023/06/28末期业绩无派息公司股份已申请周一(28日)恢复买卖。(de/d)(港股报价...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.